FORMOSA PHARMACEUTICALS , INC.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
Formosa Pharma leverages its proprietary APNT® nanoparticle formulation platform to develop a diversified pipeline, including an FDA‑approved ophthalmic nanosuspension and biosimilar or new chemical entity candidates for cancer and anti‑infective applicat
The content above was translated by Ai
Founded Year
2010
Unified Business No.
53273211
Status
Active
Number of Employees
0
Total Paid-in
Capital
1,509,771,000 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Emerging Stock Exchange(2021)、Listing(2024)
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Formosa Pharmaceuticals, Inc. is a Taipei‑based clinical‑stage biopharmaceutical company focusing on the development of novel therapies for ophthalmology and oncology.
The content above was translated by Ai
